Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hyewon Lee

Showing results (231-240 of 246) with videos related to

Pageof 25
Sort By:
Jugan Geon-Gang Gwa Jilbyeong|December 3, 2025
[Tuberculosis Treatment Outcomes in the Republic of Korea, 2023]Jaetae Kim, Soon-Young Seo, Young-Joon Park, et al.
The Science of the Total Environment|March 11, 2019
Exposure to ambient fine particles and neuropsychiatric symptoms in cognitive disorder: A repeated measure analysis from the CREDOS (Clinical Research Center for Dementia of South Korea) studyHyewon Lee, Jae Myeong Kang, Woojae Myung, et al.
The Journal of Infectious Diseases|October 14, 2017
Nucleos(t)ide Analogue Treatment for Patients With Hepatitis B Virus (HBV) e Antigen-Positive Chronic HBV Genotype C Infection: A Nationwide, Multicenter, Retrospective StudyYoung Chang, Won Hyeok Choe, Dong Hyun Sinn, et al.
Annals of Hematology|September 28, 2018
Efficacy and safety of blinatumomab treatment in adult Korean patients with relapsed/refractory acute lymphoblastic leukemia on behalf of the Korean Society of Hematology ALL Working PartySung-Hoon Jung, Se-Ryeon Lee, Deok-Hwan Yang, et al.
Blood Advances|March 6, 2024
Mutations in myeloid transcription factors and activated signaling genes predict chronic myeloid leukemia outcomesMaria Agustina Perusini, Daniela Žáčková, Taehyung Kim, et al.
Haematologica|February 2, 2023
Clonal hematopoiesis in the donor does not adversely affect long-term outcomes following allogeneic hematopoietic stem cell transplantation: result from a 13-year follow-upKyoung Ha Kim, TaeHyung Kim, Igor Novitzky-Basso, et al.
Blood|June 12, 2026
Anbalcabtagene autoleucel (PD-1 and TIGIT knockdown CD19 CAR-T) for relapsed/refractory large B-cell lymphoma (CRC01-01)Won Seog Kim, Seok Jin Kim, Dok Hyun Yoon, et al.
Experimental & Molecular Medicine|May 31, 2023
Leveraging genetic overlap between irritability and psychiatric disorders to identify genetic variants of major psychiatric disordersKyeongmin Jung, Joohyun Yoon, Yeeun Ahn, et al.
Biomed Research International|July 5, 2014
Clinical factors associated with response or survival after chemotherapy in patients with Waldenström macroglobulinemia in KoreaHo Sup Lee, Kihyun Kim, Dok Hyun Yoon, et al.
Annals of Hematology|January 4, 2020
A phase II study of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin (ESHAOx) for patients with refractory or relapsed Hodgkin's lymphomaYoung-Woong Won, Hyewon Lee, Hyeon-Seok Eom, et al.
Pageof 25

Showing results (231-240 of 246) with videos related to

Sort By:
Pageof 25
Jugan Geon-Gang Gwa Jilbyeong|December 3, 2025
[Tuberculosis Treatment Outcomes in the Republic of Korea, 2023]Jaetae Kim, Soon-Young Seo, Young-Joon Park, et al.
The Science of the Total Environment|March 11, 2019
Exposure to ambient fine particles and neuropsychiatric symptoms in cognitive disorder: A repeated measure analysis from the CREDOS (Clinical Research Center for Dementia of South Korea) studyHyewon Lee, Jae Myeong Kang, Woojae Myung, et al.
The Journal of Infectious Diseases|October 14, 2017
Nucleos(t)ide Analogue Treatment for Patients With Hepatitis B Virus (HBV) e Antigen-Positive Chronic HBV Genotype C Infection: A Nationwide, Multicenter, Retrospective StudyYoung Chang, Won Hyeok Choe, Dong Hyun Sinn, et al.
Annals of Hematology|September 28, 2018
Efficacy and safety of blinatumomab treatment in adult Korean patients with relapsed/refractory acute lymphoblastic leukemia on behalf of the Korean Society of Hematology ALL Working PartySung-Hoon Jung, Se-Ryeon Lee, Deok-Hwan Yang, et al.
Blood Advances|March 6, 2024
Mutations in myeloid transcription factors and activated signaling genes predict chronic myeloid leukemia outcomesMaria Agustina Perusini, Daniela Žáčková, Taehyung Kim, et al.
Haematologica|February 2, 2023
Clonal hematopoiesis in the donor does not adversely affect long-term outcomes following allogeneic hematopoietic stem cell transplantation: result from a 13-year follow-upKyoung Ha Kim, TaeHyung Kim, Igor Novitzky-Basso, et al.
Blood|June 12, 2026
Anbalcabtagene autoleucel (PD-1 and TIGIT knockdown CD19 CAR-T) for relapsed/refractory large B-cell lymphoma (CRC01-01)Won Seog Kim, Seok Jin Kim, Dok Hyun Yoon, et al.
Experimental & Molecular Medicine|May 31, 2023
Leveraging genetic overlap between irritability and psychiatric disorders to identify genetic variants of major psychiatric disordersKyeongmin Jung, Joohyun Yoon, Yeeun Ahn, et al.
Biomed Research International|July 5, 2014
Clinical factors associated with response or survival after chemotherapy in patients with Waldenström macroglobulinemia in KoreaHo Sup Lee, Kihyun Kim, Dok Hyun Yoon, et al.
Annals of Hematology|January 4, 2020
A phase II study of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin (ESHAOx) for patients with refractory or relapsed Hodgkin's lymphomaYoung-Woong Won, Hyewon Lee, Hyeon-Seok Eom, et al.
Pageof 25